LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

Начало・Списък с акции・NeoGenomics Inc

NeoGenomics Inc

Затворен

8.74 1.27

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

8.49

Максимум

8.86

Ключови измерители
By Trading Economics
Приходи	-7.2M -17M
Продажби	-3.5M 187M
EPS	0.01
Марж на печалбата	-9.164
Служители	2,500
EBITDA	-5.8M -567K

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+72.52% upside

Дивиденти
By Dow Jones
Следващи печалби	28.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	51M 1.2B
Предишно отваряне	7.47
Предишно затваряне	8.74

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

7.7 / 10.27 Подкрепа & съпротива

NeoGenomics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.05.2026 г., 21:03 ч. UTC

Печалби

Coinbase Global Swings to Loss Amid Softer Crypto Market

11.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

11.05.2026 г., 20:32 ч. UTC

Печалби

CleanSpark 2Q Loss/Shr $1.52 >CLSK

11.05.2026 г., 20:32 ч. UTC

Печалби

CleanSpark 2Q Rev $136.4M >CLSK

11.05.2026 г., 17:42 ч. UTC

Пазарно говорене

Zcash Gives Back Some Big Gains From Recent Days -- Market Talk

11.05.2026 г., 17:24 ч. UTC

Печалби

Circle Internet Stock Rockets After Earnings. The Stablecoin Company Is Betting on AI. -- Barrons.com

11.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

11.05.2026 г., 15:35 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

11.05.2026 г., 15:35 ч. UTC

Пазарно говорене

Altcoins Gain Traction, CoinMarketCap Index Shows -- Market Talk

11.05.2026 г., 15:20 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

11.05.2026 г., 15:20 ч. UTC

Пазарно говорене

Bitcoin Holds Over $80K Even With ETF Outflows -- Market Talk

11.05.2026 г., 14:37 ч. UTC

Печалби

Circle Internet Posts Earnings Beat but a Revenue Miss. The Stablecoin Company Is Betting on AI. -- Barrons.com

11.05.2026 г., 13:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

11.05.2026 г., 12:44 ч. UTC

Пазарно говорене

Iran War Tensions Have Mixed Implications For Bitcoin -- Market Talk

11.05.2026 г., 11:27 ч. UTC

Печалби

Circle Internet Posts Earnings Beat but a Revenue Miss. The Stablecoin Company Is Betting on AI. -- Barrons.com

11.05.2026 г., 10:40 ч. UTC

Печалби

Circle Internet Posts Earnings Beat but a Revenue Miss. The Stock Is Falling. -- Barrons.com

11.05.2026 г., 08:13 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

11.05.2026 г., 08:13 ч. UTC

Пазарно говорене

Bitcoin Steady as Investors Brush Aside Iran War Tensions -- Market Talk

8.05.2026 г., 17:04 ч. UTC

Пазарно говорене

Zcash Caps Off Parabolic Week -- Market Talk

8.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

8.05.2026 г., 15:20 ч. UTC

Пазарно говорене

'Altcoin Season' Indicator on the Rise -- Market Talk

8.05.2026 г., 15:05 ч. UTC

Пазарно говорене

Bitcoin Slips Back Below the $80k Mark -- Market Talk

8.05.2026 г., 12:19 ч. UTC

Печалби

Bitcoin Price Dives Below $80,000. This Jobs Report Could End the Crypto Slump. -- Barrons.com

8.05.2026 г., 10:55 ч. UTC

Пазарно говорене

Bitcoin Edges Higher as Risk Sentiment Improves Slightly -- Market Talk

8.05.2026 г., 08:41 ч. UTC

Печалби

Coinbase Misses Earnings and Revenue Estimates. The Stock Is Falling. -- Barrons.com

8.05.2026 г., 06:25 ч. UTC

Пазарно говорене

Bitcoin Falls as U.S. and Iran Trade Attacks -- Market Talk

7.05.2026 г., 21:25 ч. UTC

Печалби

IREN 4Q Rev $144.80M >IREN

7.05.2026 г., 20:22 ч. UTC

Печалби

Coinbase Misses on Earnings and Revenue. The Stock Is Falling. -- Barrons.com

7.05.2026 г., 14:30 ч. UTC

Пазарно говорене

Tokenized Assets Saw 22% Market Cap Jump in April -- Market Talk

7.05.2026 г., 14:25 ч. UTC

Пазарно говорене

Stablecoin Market Cap Finds New High in April -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

NeoGenomics Inc Прогноза

Ценова цел

By TipRanks

72.52% нагоре

12-месечна прогноза

Среден 14.94 USD 72.52%

Висок 25 USD

Нисък 11 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за NeoGenomics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на NeoGenomics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

7.7 / 10.27Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bearish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.